Exagen Inc. (XGN)
Exagen Inc. is a healthcare company focused on delivering advanced diagnostic tests for autoimmune diseases. Its flagship product, AVISE CTD, helps physicians diagnose systemic lupus erythematosus and other connective tissue diseases more accurately. The company integrates lab services, proprietary testing, and data analytics to improve diagnosis and disease monitoring, ultimately enhancing patient care and provider confidence.
Growth at Exagen is driven by the increasing prevalence of autoimmune conditions and a need for precise, early diagnosis. Its unique multi-biomarker testing approach distinguishes it in a competitive diagnostics space. The company partners with rheumatologists and specialists, expanding its testing base and refining its services through real-world clinical data. Adoption is also supported by payer coverage and physician education efforts.
Exagen continues to invest in research and development, aiming to expand its AVISE product portfolio and enter adjacent disease areas. Its data-driven tools support more personalized treatment decisions, aligning with value-based care trends. As awareness of autoimmune diseases grows, Exagen is positioned to be a key player in specialized diagnostics. Chart
